Key result
Aerobic exercise protects aging cardiomyocytes from ferroptosis by enhancing mitochondrial resilience and iron homeostasis.
Why the study?
Ferroptosis drives age-related cardiac dysfunction, but the molecular mechanisms underlying aerobic exercise modulation of ferroptosis remain unclear.
Does aerobic exercise prevent ferroptosis in aging cardiomyocytes?
Does aerobic exercise prevent ferroptosis in aging cardiomyocytes?
Aerobic exercise offers a promising non-pharmacological strategy to mitigate age-related cardiac dysfunction by suppressing ferroptosis via the Parkin-ACSL4 axis and improving iron homeostasis.
Should not yet change exercise guidance in aging patients; hypothesis-generating review finding leaves open need for prospective trials.
Ferroptosis, iron-dependent regulated cell death, drives age-related cardiac dysfunction. This review examines aerobic exercise modulation of ferroptosis in aging cardiomyocytes via Parkin–ACSL4 axis. Parkin promotes ACSL4 ubiquitination/degradation, reducing lipid peroxidation and ROS. Exercise activates PINK1/Parkin mitophagy and hepcidin, enhancing mitochondrial resilience and iron homeostasis. Despite promising preclinical evidence, molecular mechanisms remain unclear. Aerobic exercise offers non-pharmacological cardiac protection against ferroptosis in aging.
No takes yet. Share an insight, caveat, or question.
Kordi et al. (2026) studied this question. Aerobic exercise enhances mitochondrial resilience and iron homeostasis, offering non-pharmacological protection against ferroptosis in aging cardiomyocytes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: